Nov 13, 2023 / 09:45PM GMT
Operator
Hello, welcome to the Vir Biotechnologies AASLD late-breaking data update call. As a reminder, this conference call is being recorded. (Operator Instructions)
I will now turn the call over to Sasha Damouni Ellis, Executive Vice President, Chief Corporate Affairs Officer. You may begin, Ms. Damouni Ellis.
Sasha Damouni Ellis -
Thank you, and good afternoon. With me today are Dr. Marianne De Backer, Vir's Chief Executive Officer; and Dr. Phil Pang, Vir's Chief Medical Officer.
For the Q&A portion of the call, we will also be joined by Dr. Ed Gane, Professor of Medicine at the University of Auckland, New Zealand and Chief Hepatologist, Transplant Physician and Deputy Director of the New Zealand Liver Transplant Unit at Auckland City Hospital and Dr. Jordan Feld, the R. Phelan Chair in Translational Liver Research at the University of Toronto and Interim Director Toronto Centre for Liver Disease at Toronto General Hospital.
Before we begin, I would like to remind everyone that some of the statements we are making today are forward-looking
Vir Biotechnology Inc AASLD Late Breaking Data Update Call Transcript
Nov 14, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers